Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Roy van Heesbeen"'
Autor:
Tessa Hosman, Roy van Heesbeen, Arangassery Rosemary Bastian, Weihong Hu, Christy Comeaux, Nynke Ligtenberg, Bart van Montfort, Benoît Callendret, Esther Heijnen
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
ABSTRACTThis study assessed three Ad26.RSV.preF/RSV preF protein combinations, combining different Ad26.RSV.preF doses and naturally aged preF protein, representing the expected critical vaccine quality attributes close to release, around intermediat
Externí odkaz:
https://doaj.org/article/787203de28af43f88fb52684c0198561
Autor:
Brigitte Cheuvart, Bart Spiessens, Roy van Heesbeen, Derchieh Hung, Coralie Andrade, Joanna Korejwo-Peyramond, Fernanda Tavares-Da-Silva
Publikováno v:
Expert Review of Vaccines, Vol 22, Iss 1, Pp 849-859 (2023)
Introduction During the clinical development of a vaccine, study participants are monitored for the occurrence of adverse events (AEs) over a defined period post-vaccination to assess the safety of prophylactic vaccines. Among the safety data collect
Externí odkaz:
https://doaj.org/article/cbc911602f9340d994b7605dc8bd9913
Autor:
Marc Gurwith, Eric Evans, Frank Tomaka, Hanneke Schuitemaker, Denny Kim, Maarten Leyssen, Richard C. Condit, James S. Robertson, Dirk Heerwegh, Jerome Custers, Macaya Douoguih, Esther Heijnen, Roy van Heesbeen, Georgi Shukarev, Robert T. Chen, Emily R. Smith
Publikováno v:
Vaccine
Replication-incompetent adenoviral vectors have been under investigation as a platform to carry a variety of transgenes, and express various antigens as a basis for preventive or therapeutic vaccine development. A replication incompetent adenoviral v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::865cd876daa7b85de06e4a288170b07a
https://pubmed.ncbi.nlm.nih.gov/33676782
https://pubmed.ncbi.nlm.nih.gov/33676782